NeuroPace, Inc. NPCE
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 94.59M | 94.83M | 91.51M | 87.76M | 82.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.59M | 94.83M | 91.51M | 87.76M | 82.64M |
| Cost of Revenue | 17.58M | 18.13M | 17.50M | 16.67M | 15.94M |
| Gross Profit | 77.00M | 76.70M | 74.01M | 71.09M | 66.70M |
| SG&A Expenses | 64.28M | 65.52M | 65.92M | 63.95M | 62.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 109.14M | 111.34M | 111.06M | 108.50M | 105.27M |
| Operating Income | -14.56M | -16.50M | -19.55M | -20.74M | -22.63M |
| Income Before Tax | -18.92M | -20.54M | -24.36M | -25.87M | -28.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.92 | -20.54 | -24.36 | -25.87 | -28.39 |
| Earnings from Discontinued Operations | -- | 1.43M | 2.79M | 4.40M | 4.40M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.92M | -19.11M | -21.57M | -21.47M | -23.99M |
| EBIT | -14.56M | -16.50M | -19.55M | -20.74M | -22.63M |
| EBITDA | -14.27M | -16.24M | -19.30M | -20.50M | -22.42M |
| EPS Basic | -0.56 | -0.57 | -0.65 | -0.66 | -0.75 |
| Normalized Basic EPS | -0.35 | -0.38 | -0.45 | -0.50 | -0.56 |
| EPS Diluted | -0.56 | -0.57 | -0.65 | -0.66 | -0.75 |
| Normalized Diluted EPS | -0.35 | -0.38 | -0.45 | -0.50 | -0.56 |
| Average Basic Shares Outstanding | 135.55M | 134.34M | 133.10M | 130.87M | 127.40M |
| Average Diluted Shares Outstanding | 135.55M | 134.34M | 133.10M | 130.87M | 127.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |